Overcoming inefficiencies to improve access to cell and gene therapy
Drug Discovery World
MARCH 13, 2023
The cell and gene therapy (CGT) landscape has grown significantly in the past year. Between the 24 therapies already approved by the FDA 1 and a marked increase in clinical trials, widespread accessibility to precision medicine feels within reach. But this kind of change can’t happen in a bubble.
52 
Let's personalize your content